BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12807747)

  • 1. Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582.
    Lima J; Máximo V; Soares P; Williams D; Bogdanova T; Thomas GA; Sobrinho-Simões M
    Carcinogenesis; 2003 Jun; 24(6):1155. PubMed ID: 12807747
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential mutation frequency in mitochondrial DNA from thyroid tumours.
    Lohrer HD; Hieber L; Zitzelsberger H
    Carcinogenesis; 2002 Oct; 23(10):1577-82. PubMed ID: 12376464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid.
    Máximo V; Sobrinho-Simões M
    J Pathol; 2000 Dec; 192(4):561-2. PubMed ID: 11113879
    [No Abstract]   [Full Text] [Related]  

  • 4. Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer.
    Kimmel RR; Zhao LP; Nguyen D; Lee S; Aronszajn M; Cheng C; Troshin VP; Abrosimov A; Delrow J; Tuttle RM; Tsyb AF; Kopecky KJ; Davis S; Neiman PE
    Radiat Res; 2006 Sep; 166(3):519-31. PubMed ID: 16953671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repair of mitochondrial DNA in aging and carcinogenesis.
    Berneburg M; Kamenisch Y; Krutmann J
    Photochem Photobiol Sci; 2006 Feb; 5(2):190-8. PubMed ID: 16465305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial A135149 mutation without MELAS but in association with papillary thyroid carcinoma.
    Abu-Amero K; Zou M; Shi Y
    Clin Genet; 2004 Dec; 66(6):569-70. PubMed ID: 15521990
    [No Abstract]   [Full Text] [Related]  

  • 7. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
    Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
    Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.
    Powell N; Jeremiah S; Morishita M; Dudley E; Bethel J; Bogdanova T; Tronko M; Thomas G
    J Pathol; 2005 Apr; 205(5):558-64. PubMed ID: 15714593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
    Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
    Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cancer in two siblings with FAP syndrome and APC mutation.
    Brozek I; Plawski A; Podralska M; Kanka C; Slomski R; Limon J
    Int J Colorectal Dis; 2008 Mar; 23(3):331-2. PubMed ID: 17665205
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.
    Bertagnolli AC; Soares P; van Asch B; Amorim A; Cirnes L; Máximo V; Cassali GD
    Vet J; 2009 Nov; 182(2):269-74. PubMed ID: 18752974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion.
    Lee HC; Hsu LS; Yin PH; Lee LM; Chi CW
    Mitochondrion; 2007; 7(1-2):157-63. PubMed ID: 17280876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA mutations in human disease.
    Greaves LC; Taylor RW
    IUBMB Life; 2006 Mar; 58(3):143-51. PubMed ID: 16766381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations in the mitochondrial control region DNA in breast tissue.
    Rosson D; Keshgegian AA
    Cancer Lett; 2004 Nov; 215(1):89-94. PubMed ID: 15374637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
    Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mitochondrial mutations in melanoma resection specimens.
    Deichmann M; Kahle B; Benner A; Thome M; Helmke B; Näher H
    Int J Oncol; 2004 Jan; 24(1):137-41. PubMed ID: 14654950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.